Click for best price
Pancreatic Bile Duct Cancer Drug Market Size, Share 2023
It is a drug for treating pancreatic cancer with bile duct cancer.
This report aims to provide a comprehensive presentation of the global market for Pancreatic and Bile Duct Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic and Bile Duct Cancer Drug. This report contains market size and forecasts of Pancreatic and Bile Duct Cancer Drug in global, including the following market information:
Global Pancreatic and Bile Duct Cancer Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pancreatic and Bile Duct Cancer Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive juice and insulin.
Symptoms and signs include upper abdominal pain, yellowish skin and white eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Susceptibility factors include age, gender, smoking, diabetes, and family history. Treatment includes surgery, chemotherapy and radiation therapy.
Cholangiocarcinoma or cholangiocarcinoma is a tumor that occurs in the bile duct. A series of tubes in the bile duct are essential for bile secretion, and bile plays an important role in digestion. Symptoms include abdominal discomfort, loss of appetite, fever and weight loss. Treatment includes chemotherapy and radiation therapy.
We surveyed the Pancreatic and Bile Duct Cancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pancreatic and Bile Duct Cancer Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Pancreatic and Bile Duct Cancer Drug Market Segment Percentages, by Type, 2022 (%)
Vascular Endothelial Growth Factor Receptors
Programmed Cell Death Protein 1
Signal Transducer Activator of Transcription 3
Others
Global Pancreatic and Bile Duct Cancer Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Pancreatic and Bile Duct Cancer Drug Market Segment Percentages, by Application, 2022 (%)
Pancreatic Cancer
Cholangiocarcinoma
Global Pancreatic and Bile Duct Cancer Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Pancreatic and Bile Duct Cancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pancreatic and Bile Duct Cancer Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pancreatic and Bile Duct Cancer Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3-V Biosciences Inc
4P-Pharma SAS
4SC AG
AB Science SA
AbbVie Inc
AbGenomics International Inc
Ability Pharmaceuticals SL
Aclaris Therapeutics Inc
Actuate Therapeutics Inc
Aduro BioTech Inc
Advantagene Inc
AGV Discovery SAS
AIMM Therapeutics BV
Alissa Pharma
Alligator Bioscience AB
Allinky Biopharma
Altor BioScience Corp
amcure GmbH
Amgen Inc
Amplia Therapeutics Pty Ltd
Anavex Life Sciences Corp
Andarix Pharmaceuticals Inc
ANP Technologies Inc
AntiCancer Inc
APEIRON Biologics AG
Apexigen Inc
Aphios Corp
Aposense Ltd
ARMO Biosciences Inc
ArQule Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pancreatic and Bile Duct Cancer Drug, market overview.
Chapter 2: Global Pancreatic and Bile Duct Cancer Drug market size in revenue.
Chapter 3: Detailed analysis of Pancreatic and Bile Duct Cancer Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pancreatic and Bile Duct Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pancreatic and Bile Duct Cancer Drug Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pancreatic and Bile Duct Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pancreatic and Bile Duct Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pancreatic and Bile Duct Cancer Drug Overall Market Size
2.1 Global Pancreatic and Bile Duct Cancer Drug Market Size: 2022 VS 2030
2.2 Global Pancreatic and Bile Duct Cancer Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pancreatic and Bile Duct Cancer Drug Players in Global Market
3.2 Top Global Pancreatic and Bile Duct Cancer Drug Companies Ranked by Revenue
3.3 Global Pancreatic and Bile Duct Cancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Pancreatic and Bile Duct Cancer Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pancreatic and Bile Duct Cancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pancreatic and Bile Duct Cancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Pancreatic and Bile Duct Cancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Pancreatic and Bile Duct Cancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pancreatic and Bile Duct Cancer Drug Market Size Markets, 2022 & 2030
4.1.2 Vascular Endothelial Growth Factor Receptors
4.1.3 Programmed Cell Death Protein 1
4.1.4 Signal Transducer Activator of Transcription 3
4.1.5 Others
4.2 By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2023
4.2.2 By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue, 2024-2030
4.2.3 By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pancreatic and Bile Duct Cancer Drug Market Size, 2022 & 2030
5.1.2 Pancreatic Cancer
5.1.3 Cholangiocarcinoma
5.2 By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2023
5.2.2 By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue, 2024-2030
5.2.3 By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Pancreatic and Bile Duct Cancer Drug Market Size, 2022 & 2030
6.2 By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2023
6.2.2 By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue, 2024-2030
6.2.3 By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2030
6.3.2 US Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.3.3 Canada Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.3.4 Mexico Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2030
6.4.2 Germany Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4.3 France Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4.4 U.K. Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4.5 Italy Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4.6 Russia Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4.7 Nordic Countries Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.4.8 Benelux Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2030
6.5.2 China Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.5.3 Japan Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.5.4 South Korea Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.5.5 Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.5.6 India Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2030
6.6.2 Brazil Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.6.3 Argentina Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2030
6.7.2 Turkey Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.7.3 Israel Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
6.7.5 UAE Pancreatic and Bile Duct Cancer Drug Market Size, 2018-2030
7 Pancreatic and Bile Duct Cancer Drug Companies Profiles
7.1 3-V Biosciences Inc
7.1.1 3-V Biosciences Inc Company Summary
7.1.2 3-V Biosciences Inc Business Overview
7.1.3 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.1.4 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.1.5 3-V Biosciences Inc Key News & Latest Developments
7.2 4P-Pharma SAS
7.2.1 4P-Pharma SAS Company Summary
7.2.2 4P-Pharma SAS Business Overview
7.2.3 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.2.4 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.2.5 4P-Pharma SAS Key News & Latest Developments
7.3 4SC AG
7.3.1 4SC AG Company Summary
7.3.2 4SC AG Business Overview
7.3.3 4SC AG Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.3.4 4SC AG Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.3.5 4SC AG Key News & Latest Developments
7.4 AB Science SA
7.4.1 AB Science SA Company Summary
7.4.2 AB Science SA Business Overview
7.4.3 AB Science SA Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.4.4 AB Science SA Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.4.5 AB Science SA Key News & Latest Developments
7.5 AbbVie Inc
7.5.1 AbbVie Inc Company Summary
7.5.2 AbbVie Inc Business Overview
7.5.3 AbbVie Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.5.4 AbbVie Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.5.5 AbbVie Inc Key News & Latest Developments
7.6 AbGenomics International Inc
7.6.1 AbGenomics International Inc Company Summary
7.6.2 AbGenomics International Inc Business Overview
7.6.3 AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.6.4 AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.6.5 AbGenomics International Inc Key News & Latest Developments
7.7 Ability Pharmaceuticals SL
7.7.1 Ability Pharmaceuticals SL Company Summary
7.7.2 Ability Pharmaceuticals SL Business Overview
7.7.3 Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.7.4 Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.7.5 Ability Pharmaceuticals SL Key News & Latest Developments
7.8 Aclaris Therapeutics Inc
7.8.1 Aclaris Therapeutics Inc Company Summary
7.8.2 Aclaris Therapeutics Inc Business Overview
7.8.3 Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.8.4 Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.8.5 Aclaris Therapeutics Inc Key News & Latest Developments
7.9 Actuate Therapeutics Inc
7.9.1 Actuate Therapeutics Inc Company Summary
7.9.2 Actuate Therapeutics Inc Business Overview
7.9.3 Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.9.4 Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.9.5 Actuate Therapeutics Inc Key News & Latest Developments
7.10 Aduro BioTech Inc
7.10.1 Aduro BioTech Inc Company Summary
7.10.2 Aduro BioTech Inc Business Overview
7.10.3 Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.10.4 Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.10.5 Aduro BioTech Inc Key News & Latest Developments
7.11 Advantagene Inc
7.11.1 Advantagene Inc Company Summary
7.11.2 Advantagene Inc Business Overview
7.11.3 Advantagene Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.11.4 Advantagene Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.11.5 Advantagene Inc Key News & Latest Developments
7.12 AGV Discovery SAS
7.12.1 AGV Discovery SAS Company Summary
7.12.2 AGV Discovery SAS Business Overview
7.12.3 AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.12.4 AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.12.5 AGV Discovery SAS Key News & Latest Developments
7.13 AIMM Therapeutics BV
7.13.1 AIMM Therapeutics BV Company Summary
7.13.2 AIMM Therapeutics BV Business Overview
7.13.3 AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.13.4 AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.13.5 AIMM Therapeutics BV Key News & Latest Developments
7.14 Alissa Pharma
7.14.1 Alissa Pharma Company Summary
7.14.2 Alissa Pharma Business Overview
7.14.3 Alissa Pharma Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.14.4 Alissa Pharma Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.14.5 Alissa Pharma Key News & Latest Developments
7.15 Alligator Bioscience AB
7.15.1 Alligator Bioscience AB Company Summary
7.15.2 Alligator Bioscience AB Business Overview
7.15.3 Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.15.4 Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.15.5 Alligator Bioscience AB Key News & Latest Developments
7.16 Allinky Biopharma
7.16.1 Allinky Biopharma Company Summary
7.16.2 Allinky Biopharma Business Overview
7.16.3 Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.16.4 Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.16.5 Allinky Biopharma Key News & Latest Developments
7.17 Altor BioScience Corp
7.17.1 Altor BioScience Corp Company Summary
7.17.2 Altor BioScience Corp Business Overview
7.17.3 Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.17.4 Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.17.5 Altor BioScience Corp Key News & Latest Developments
7.18 amcure GmbH
7.18.1 amcure GmbH Company Summary
7.18.2 amcure GmbH Business Overview
7.18.3 amcure GmbH Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.18.4 amcure GmbH Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.18.5 amcure GmbH Key News & Latest Developments
7.19 Amgen Inc
7.19.1 Amgen Inc Company Summary
7.19.2 Amgen Inc Business Overview
7.19.3 Amgen Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.19.4 Amgen Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.19.5 Amgen Inc Key News & Latest Developments
7.20 Amplia Therapeutics Pty Ltd
7.20.1 Amplia Therapeutics Pty Ltd Company Summary
7.20.2 Amplia Therapeutics Pty Ltd Business Overview
7.20.3 Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.20.4 Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.20.5 Amplia Therapeutics Pty Ltd Key News & Latest Developments
7.21 Anavex Life Sciences Corp
7.21.1 Anavex Life Sciences Corp Company Summary
7.21.2 Anavex Life Sciences Corp Business Overview
7.21.3 Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.21.4 Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.21.5 Anavex Life Sciences Corp Key News & Latest Developments
7.22 Andarix Pharmaceuticals Inc
7.22.1 Andarix Pharmaceuticals Inc Company Summary
7.22.2 Andarix Pharmaceuticals Inc Business Overview
7.22.3 Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.22.4 Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.22.5 Andarix Pharmaceuticals Inc Key News & Latest Developments
7.23 ANP Technologies Inc
7.23.1 ANP Technologies Inc Company Summary
7.23.2 ANP Technologies Inc Business Overview
7.23.3 ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.23.4 ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.23.5 ANP Technologies Inc Key News & Latest Developments
7.24 AntiCancer Inc
7.24.1 AntiCancer Inc Company Summary
7.24.2 AntiCancer Inc Business Overview
7.24.3 AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.24.4 AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.24.5 AntiCancer Inc Key News & Latest Developments
7.25 APEIRON Biologics AG
7.25.1 APEIRON Biologics AG Company Summary
7.25.2 APEIRON Biologics AG Business Overview
7.25.3 APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.25.4 APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.25.5 APEIRON Biologics AG Key News & Latest Developments
7.26 Apexigen Inc
7.26.1 Apexigen Inc Company Summary
7.26.2 Apexigen Inc Business Overview
7.26.3 Apexigen Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.26.4 Apexigen Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.26.5 Apexigen Inc Key News & Latest Developments
7.27 Aphios Corp
7.27.1 Aphios Corp Company Summary
7.27.2 Aphios Corp Business Overview
7.27.3 Aphios Corp Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.27.4 Aphios Corp Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.27.5 Aphios Corp Key News & Latest Developments
7.28 Aposense Ltd
7.28.1 Aposense Ltd Company Summary
7.28.2 Aposense Ltd Business Overview
7.28.3 Aposense Ltd Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.28.4 Aposense Ltd Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.28.5 Aposense Ltd Key News & Latest Developments
7.29 ARMO Biosciences Inc
7.29.1 ARMO Biosciences Inc Company Summary
7.29.2 ARMO Biosciences Inc Business Overview
7.29.3 ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.29.4 ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.29.5 ARMO Biosciences Inc Key News & Latest Developments
7.30 ArQule Inc
7.30.1 ArQule Inc Company Summary
7.30.2 ArQule Inc Business Overview
7.30.3 ArQule Inc Pancreatic and Bile Duct Cancer Drug Major Product Offerings
7.30.4 ArQule Inc Pancreatic and Bile Duct Cancer Drug Revenue in Global Market (2018-2023)
7.30.5 ArQule Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pancreatic and Bile Duct Cancer Drug Market Opportunities & Trends in Global Market
Table 2. Pancreatic and Bile Duct Cancer Drug Market Drivers in Global Market
Table 3. Pancreatic and Bile Duct Cancer Drug Market Restraints in Global Market
Table 4. Key Players of Pancreatic and Bile Duct Cancer Drug in Global Market
Table 5. Top Pancreatic and Bile Duct Cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pancreatic and Bile Duct Cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pancreatic and Bile Duct Cancer Drug Product Type
Table 9. List of Global Tier 1 Pancreatic and Bile Duct Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic and Bile Duct Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Pancreatic and Bile Duct Cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pancreatic and Bile Duct Cancer Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Pancreatic and Bile Duct Cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pancreatic and Bile Duct Cancer Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2024-2030
Table 30. 3-V Biosciences Inc Company Summary
Table 31. 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 32. 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 33. 3-V Biosciences Inc Key News & Latest Developments
Table 34. 4P-Pharma SAS Company Summary
Table 35. 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 36. 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 37. 4P-Pharma SAS Key News & Latest Developments
Table 38. 4SC AG Company Summary
Table 39. 4SC AG Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 40. 4SC AG Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 41. 4SC AG Key News & Latest Developments
Table 42. AB Science SA Company Summary
Table 43. AB Science SA Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 44. AB Science SA Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 45. AB Science SA Key News & Latest Developments
Table 46. AbbVie Inc Company Summary
Table 47. AbbVie Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 48. AbbVie Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 49. AbbVie Inc Key News & Latest Developments
Table 50. AbGenomics International Inc Company Summary
Table 51. AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 52. AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AbGenomics International Inc Key News & Latest Developments
Table 54. Ability Pharmaceuticals SL Company Summary
Table 55. Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 56. Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Ability Pharmaceuticals SL Key News & Latest Developments
Table 58. Aclaris Therapeutics Inc Company Summary
Table 59. Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 60. Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Aclaris Therapeutics Inc Key News & Latest Developments
Table 62. Actuate Therapeutics Inc Company Summary
Table 63. Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 64. Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Actuate Therapeutics Inc Key News & Latest Developments
Table 66. Aduro BioTech Inc Company Summary
Table 67. Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 68. Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Aduro BioTech Inc Key News & Latest Developments
Table 70. Advantagene Inc Company Summary
Table 71. Advantagene Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 72. Advantagene Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Advantagene Inc Key News & Latest Developments
Table 74. AGV Discovery SAS Company Summary
Table 75. AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 76. AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 77. AGV Discovery SAS Key News & Latest Developments
Table 78. AIMM Therapeutics BV Company Summary
Table 79. AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 80. AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 81. AIMM Therapeutics BV Key News & Latest Developments
Table 82. Alissa Pharma Company Summary
Table 83. Alissa Pharma Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 84. Alissa Pharma Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Alissa Pharma Key News & Latest Developments
Table 86. Alligator Bioscience AB Company Summary
Table 87. Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 88. Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 89. Alligator Bioscience AB Key News & Latest Developments
Table 90. Allinky Biopharma Company Summary
Table 91. Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 92. Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 93. Allinky Biopharma Key News & Latest Developments
Table 94. Altor BioScience Corp Company Summary
Table 95. Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 96. Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 97. Altor BioScience Corp Key News & Latest Developments
Table 98. amcure GmbH Company Summary
Table 99. amcure GmbH Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 100. amcure GmbH Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 101. amcure GmbH Key News & Latest Developments
Table 102. Amgen Inc Company Summary
Table 103. Amgen Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 104. Amgen Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 105. Amgen Inc Key News & Latest Developments
Table 106. Amplia Therapeutics Pty Ltd Company Summary
Table 107. Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 108. Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 109. Amplia Therapeutics Pty Ltd Key News & Latest Developments
Table 110. Anavex Life Sciences Corp Company Summary
Table 111. Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 112. Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 113. Anavex Life Sciences Corp Key News & Latest Developments
Table 114. Andarix Pharmaceuticals Inc Company Summary
Table 115. Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 116. Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 117. Andarix Pharmaceuticals Inc Key News & Latest Developments
Table 118. ANP Technologies Inc Company Summary
Table 119. ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 120. ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 121. ANP Technologies Inc Key News & Latest Developments
Table 122. AntiCancer Inc Company Summary
Table 123. AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 124. AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 125. AntiCancer Inc Key News & Latest Developments
Table 126. APEIRON Biologics AG Company Summary
Table 127. APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 128. APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 129. APEIRON Biologics AG Key News & Latest Developments
Table 130. Apexigen Inc Company Summary
Table 131. Apexigen Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 132. Apexigen Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 133. Apexigen Inc Key News & Latest Developments
Table 134. Aphios Corp Company Summary
Table 135. Aphios Corp Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 136. Aphios Corp Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 137. Aphios Corp Key News & Latest Developments
Table 138. Aposense Ltd Company Summary
Table 139. Aposense Ltd Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 140. Aposense Ltd Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 141. Aposense Ltd Key News & Latest Developments
Table 142. ARMO Biosciences Inc Company Summary
Table 143. ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 144. ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 145. ARMO Biosciences Inc Key News & Latest Developments
Table 146. ArQule Inc Company Summary
Table 147. ArQule Inc Pancreatic and Bile Duct Cancer Drug Product Offerings
Table 148. ArQule Inc Pancreatic and Bile Duct Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 149. ArQule Inc Key News & Latest Developments
List of Figures
Figure 1. Pancreatic and Bile Duct Cancer Drug Segment by Type in 2022
Figure 2. Pancreatic and Bile Duct Cancer Drug Segment by Application in 2022
Figure 3. Global Pancreatic and Bile Duct Cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pancreatic and Bile Duct Cancer Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Pancreatic and Bile Duct Cancer Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pancreatic and Bile Duct Cancer Drug Revenue in 2022
Figure 8. By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 16. US Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 20. Germany Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 28. China Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Pancreatic and Bile Duct Cancer Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Pancreatic and Bile Duct Cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 41. 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. 4SC AG Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AB Science SA Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AbbVie Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Advantagene Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Alissa Pharma Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. amcure GmbH Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Amgen Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Apexigen Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Aphios Corp Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Aposense Ltd Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 70. ArQule Inc Pancreatic and Bile Duct Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
